New Product Express Issue 025 | Impurities of Four Core Cardiovascular Drugs Launched, Full Set of Compliant Spectra to Support R&D
New Product Express Issue 025 | Impurities of Four Core Cardiovascular Drugs Launched, Full Set of Compliant Spectra to Support R&D
Introduction: Impurity research of cardiovascular drugs: from "large quantity" to "high quality"Cardiovascular disease has long ranked first among global causes of death, and the market scale of related drugs is huge. From classic β-receptor blockers to first-line antihypertensive...
Overcoming Synthetic Challenges: Custom Synthesis and Structural Elucidation of Upadacitinib Impurity 15
Overcoming Synthetic Challenges: Custom Synthesis and Structural Elucidation of Upadacitinib Impurity 15
ForewordUpatinib (Upadacitinib, Figure 1) is a highly efficient and selective JAK1 inhibitor. In biochemical assays, its selectivity for JAK-1 is 74 times higher than that for JAK-2 (involved in erythropoiesis) and 58 times higher than that for JAK-3 (involved in immune surveillan...
New Product Express Issue 024 | New Impurities for Antiviral and Clinically Common Drugs Launched, Full Set of Compliance Spectra to Safeguard R&D
New Product Express Issue 024 | New Impurities for Antiviral and Clinically Common Drugs Launched, Full Set of Compliance Spectra to Safeguard R&D
Introduction: The "New Challenges" of High-Frequency Drug ImpuritiesFrom the antiviral drug Peramivir used during flu season, to the new-generation acid-suppressing drug Tegoprazan; from the classic glucocorticoid Hydrocortisone, to the monobactam antibiotic Aztreonam, and the wel...
New Product Express Issue 023 | CNS Neuropsychiatric Drug Impurities New, Full Set of Compliance Map Escort Research and Development
New Product Express Issue 023 | CNS Neuropsychiatric Drug Impurities New, Full Set of Compliance Map Escort Research and Development
Introduction: The "Invisible Barrier" Behind a $130B MarketAccording to IQVIA, the global CNS therapeutics market surpassed $130 billion in 2025, growing at a CAGR exceeding 6%. However, impurity profiling in this field faces hurdles far exceeding those of standard small molecules...
New Product Express Issue 022 | New Oncology-Targeted & Immunomodulatory Impurities Added — Full Compliant Certificates to Empower Your R&D
New Product Express Issue 022 | New Oncology-Targeted & Immunomodulatory Impurities Added — Full Compliant Certificates to Empower Your R&D
Lead-in: The "Purity Battle" of Targeted TherapiesIn the R&D landscape of innovative and high-end generic drugs, API (Active Pharmaceutical Ingredient) quality control remains the decisive factor between success and failure. As NMPA and FDA requirements for genotoxic impuritie...
New Arrivals Issue 021 | Four hot tracks of impurities just launched, full set of compliant charts to support R&D
New Arrivals Issue 021 | Four hot tracks of impurities just launched, full set of compliant charts to support R&D
New Arrivals Issue 021 | Four hot tracks of impurities just launched, full set of compliant charts to support R&D
Advancing Stability Studies: High-Purity Fructosazine Reference Standards Now Mass-Produced
Advancing Stability Studies: High-Purity Fructosazine Reference Standards Now Mass-Produced
CAT#: G26114Key Advantages:Ample stock available. Batch capacity exceeds 20g. Purity ≥95%.Inquiries welcome.
Invitation | June 16-18: SINCO Exhibiting at CPHI Shanghai.
Invitation | June 16-18: SINCO Exhibiting at CPHI Shanghai.
Scan to pre-register and explore the future of pharmaceutical analysis with SINCO
How to Access and Navigate Sinco's Official Website
How to Access and Navigate Sinco's Official Website
Dear valued customersTo further enhance userexperience, Sinco website has undergone significant updates. This upgrade focuses on improving the accuracy of spot product filtering, enhancing the efficiency of bulk inquiries, and personalizing service content display. The updated fea...
Kind Attention | Sinco's Trade-mark, product label and COA were upgraded
Kind Attention | Sinco's Trade-mark, product label and COA were upgraded
Dear Customers and Partners:Fristly, I would like to extend our appreciation for your long-term support in Sinco's development! To constantly improve your experience in buying and using Sinco's products, we have upgraded our trade-mark, label and COA. It will make you more easily ...